Professional CGM System Improves Glucose Control
By HospiMedica International staff writers Posted on 25 Jun 2014 |
Image: The Dexcom G4 PLATINUM Professional CGM (Photo courtesy of ourtesy Dexcom).
A professional continuous glucose monitoring (CGM) system allows doctors and patients to review glucose data retrospectively, assisting therapeutic treatment management.
The Dexcom G4 PLATINUM Professional CGM consists of a practice-owned professional CGM system and sensors. Patients are first placed on the device for a period of seven days, with two calibration measurements using a blood glucose meter performed daily. Dynamic and comprehensive data is collected and shared with the patient, which aids in their understanding of the impact between behavior and glucose activity. Clinicians can use these insights to adjust therapy and to educate and motivate patients to modify their behavior after viewing the effects that specific foods, exercise, stress, and medications have on their glucose levels.
Following setup, the system provides continuous readings on the rate and direction of glucose change up to every five minutes, supporting therapy adjustments and treatment recommendations. The system can also be customized for personalized glucose targets and alerts, and has an alarm feature to alert the user if glucose levels rise or fall to dangerous levels. The system has an extended 6-meter range1, and a sleek receiver available in three vibrant colors. The Dexcom G4 PLATINUM Professional CGM is a product of Dexcom (San Diego, CA, USA), and has been approved by the US Food and Drug Administration (FDA).
“Dexcom’s mission is to provide doctors, patients and caregivers new medical technology to improve their understanding and management of diabetes,” said Terrance H. Gregg, CEO of Dexcom. “The G4 PLATINUM Professional is Dexcom’s latest answer for healthcare professionals and patients seeking novel and insightful tools to optimize therapeutic decisions.”
The traditional standard-of-care for glucose monitoring is a finger stick meter. CGM thus represents the most significant breakthrough in diabetes management in the past 40 years, augmenting the use of glucose meters for the management of diabetes by providing real-time glucose changes with the push of a button, alerting users when glucose is too low or too high. Finger stick meters are still required to calibrate CGMs and for making therapy and meal decisions.
Related Links:
Dexcom
The Dexcom G4 PLATINUM Professional CGM consists of a practice-owned professional CGM system and sensors. Patients are first placed on the device for a period of seven days, with two calibration measurements using a blood glucose meter performed daily. Dynamic and comprehensive data is collected and shared with the patient, which aids in their understanding of the impact between behavior and glucose activity. Clinicians can use these insights to adjust therapy and to educate and motivate patients to modify their behavior after viewing the effects that specific foods, exercise, stress, and medications have on their glucose levels.
Following setup, the system provides continuous readings on the rate and direction of glucose change up to every five minutes, supporting therapy adjustments and treatment recommendations. The system can also be customized for personalized glucose targets and alerts, and has an alarm feature to alert the user if glucose levels rise or fall to dangerous levels. The system has an extended 6-meter range1, and a sleek receiver available in three vibrant colors. The Dexcom G4 PLATINUM Professional CGM is a product of Dexcom (San Diego, CA, USA), and has been approved by the US Food and Drug Administration (FDA).
“Dexcom’s mission is to provide doctors, patients and caregivers new medical technology to improve their understanding and management of diabetes,” said Terrance H. Gregg, CEO of Dexcom. “The G4 PLATINUM Professional is Dexcom’s latest answer for healthcare professionals and patients seeking novel and insightful tools to optimize therapeutic decisions.”
The traditional standard-of-care for glucose monitoring is a finger stick meter. CGM thus represents the most significant breakthrough in diabetes management in the past 40 years, augmenting the use of glucose meters for the management of diabetes by providing real-time glucose changes with the push of a button, alerting users when glucose is too low or too high. Finger stick meters are still required to calibrate CGMs and for making therapy and meal decisions.
Related Links:
Dexcom
Latest Critical Care News
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration